SCOPUS BIOPHARMA INC's ticker is SCPS and the CUSIP is 809171101. A total of 18 filers reported holding SCOPUS BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $14,000 | -70.2% | 32,966 | -51.5% | 0.00% | -100.0% |
Q1 2022 | $47,000 | -69.5% | 67,966 | -27.7% | 0.00% | -66.7% |
Q4 2021 | $154,000 | -47.6% | 93,966 | +32.6% | 0.00% | -50.0% |
Q3 2021 | $294,000 | -12.5% | 70,866 | +50.7% | 0.01% | 0.0% |
Q2 2021 | $336,000 | -15.4% | 47,009 | 0.0% | 0.01% | -14.3% |
Q1 2021 | $397,000 | – | 47,009 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M&R CAPITAL MANAGEMENT INC | 76,819 | $33,000 | 0.01% |
VANGUARD GROUP INC | 54,649 | $24,000 | 0.00% |
UBS Group AG | 100 | $0 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 32,966 | $14,000 | 0.00% |
Compagnie Lombard Odier SCmA | 4,360 | $2,000 | 0.00% |
FIRST MANHATTAN CO. LLC. | 25,800 | $11,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 89 | $0 | 0.00% |
NORTHERN TRUST CORP | 12,516 | $5,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 217,078 | $93,000 | 0.00% |